Pfizer chief open to acquisitions

piggy submitted, created time 2 days 4 hours (www.reuters.com)

Pfizer Inc., the world's biggest pharmaceutical group, is open to acquisitions, its chief executive Jeff Kindler told the Financial Times in an interview.
"The real goal is to grow revenues ... We are open to opportunities and constantly looking at those which are big, small and in-between," Kindler told the paper.

Sales of Lipitor, Pfizer's $12 billion-a-year cholesterol fighter, are set to fall in 2011 when generic versions are slated to hit the market

1 comment | Blog It | Email It | Keywords: generic drugs generics patents cholesterol lipitor acquisitions Pfizer

Pfizer ends development of obesity drug

piggy submitted, created time 2 months 1 day (www.reuters.com)

NEW YORK, Nov 5 (Reuters) - Pfizer Inc on Wednesday became the latest drugmaker to abandon an obesity treatment that works by blocking the receptors in the brain that makes people hungry after smoking marijuana.

The world's largest drugmaker said it was terminating late stage development of its experimental obesity drug, CP-945,598, citing a more conservative regulatory climate and problems seen with other medicines from the same class

4 comments | Blog It | Email It | Keywords: illegal drugs illicit drugs drugs appetite marijuana Pfizer Obesity obesity treatment

Is Dr. Jarvik qualified to be a professional spokesman for Lipitor?

Darkfrog submitted, created time 11 months 21 hours (www.nytimes.com)

Dr. Jarvik is famous for inventing a workable artificial heart, but he's not a cardiologist or even licensed to practice medicine. So why is he the face of choice for all those Lipitor ads? This article explores the propriety of these advertisements and lists inquiries into their ethics.

Dr. Jarvik isn' t just a celebrity face or a friendly testimonial. The use of his name implies some kind of expert endorsement, which he is not necessarily qualified to make

1 comment | Blog It | Email It | Keywords: advertisements advertising marketing ethics Lipitor Pfizer cholesterol drugs prescription drugs science and culture